These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29883667)

  • 1. Protein-Excipient Interactions Evaluated via Nuclear Magnetic Resonance Studies in Polysorbate-Based Multidose Protein Formulations: Influence on Antimicrobial Efficacy and Potential Study Approach.
    Torosantucci R; Furtmann B; Elshorst B; Pfeiffer-Marek S; Hartleb T; Andres N; Bussemer T
    J Pharm Sci; 2018 Oct; 107(10):2531-2537. PubMed ID: 29883667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanism of Antimicrobial Excipient-Induced Aggregation in Parenteral Formulations of Peptide Therapeutics.
    Li M; Falk BT; Lu X; Schroder R; Mccoy M; Xu W; Yin DH; Gindy ME; D'Addio SM; Su Y
    Mol Pharm; 2022 Sep; 19(9):3267-3278. PubMed ID: 35917158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions Between Peptide and Preservatives: Effects on Peptide Self-Interactions and Antimicrobial Efficiency In Aqueous Multi-Dose Formulations.
    Heljo P; Ross A; Zarraga IE; Pappenberger A; Mahler HC
    Pharm Res; 2015 Oct; 32(10):3201-12. PubMed ID: 25893328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.
    Kerwin BA
    J Pharm Sci; 2008 Aug; 97(8):2924-35. PubMed ID: 17973307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and assessment of suitability of trehalose fatty acid esters as alternatives for polysorbates in protein formulation.
    Schiefelbein L; Keller M; Weissmann F; Luber M; Bracher F; Friess W
    Eur J Pharm Biopharm; 2010 Nov; 76(3):342-50. PubMed ID: 20816956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics.
    Kishore RS; Kiese S; Fischer S; Pappenberger A; Grauschopf U; Mahler HC
    Pharm Res; 2011 May; 28(5):1194-210. PubMed ID: 21369824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.
    Singh SM; Bandi S; Jones DNM; Mallela KMG
    J Pharm Sci; 2017 Dec; 106(12):3486-3498. PubMed ID: 28843351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the Stabilization of Interferon Alpha by Two Surfactants Revealed by STD-NMR Spectroscopy.
    Svilenov HL; Kopp KT; Golovanov AP; Winter G; Zalar M
    J Pharm Sci; 2023 Feb; 112(2):404-410. PubMed ID: 36257338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of low concentrations of polysorbates 80 in protein formulations by Coomassie brilliant blue.
    Cheng Y; Liu Y; Wei H; Sun R; Tian Z; Zheng X
    Anal Biochem; 2019 May; 573():67-72. PubMed ID: 30853377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw material.
    Siska CC; Pierini CJ; Lau HR; Latypov RF; Fesinmeyer RM; Litowski JR
    J Pharm Sci; 2015 Feb; 104(2):447-56. PubMed ID: 25196966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMC determination of nonionic surfactants in protein formulations using ultrasonic resonance technology.
    Horiuchi S; Winter G
    Eur J Pharm Biopharm; 2015 May; 92():8-14. PubMed ID: 25684280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant Impact on Interfacial Protein Aggregation and Utilization of Surface Tension to Predict Surfactant Requirements for Biological Formulations.
    Vargo KB; Stahl P; Hwang B; Hwang E; Giordano D; Randolph P; Celentano C; Hepler R; Amin K
    Mol Pharm; 2021 Jan; 18(1):148-157. PubMed ID: 33253579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments of Polysorbate (Tween) based microemulsions: Preclinical drug delivery, toxicity and antimicrobial applications.
    Kaur G; Mehta SK
    Int J Pharm; 2017 Aug; 529(1-2):134-160. PubMed ID: 28642203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the Influence of Polysorbate 20/80 and Polaxomer P188 on the Surface & Interfacial Properties of Bovine Serum Albumin and Lysozyme.
    Begum F; Amin S
    Pharm Res; 2019 May; 36(7):107. PubMed ID: 31111248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant-mediated dissolution of metformin hydrochloride tablets: wetting effects versus ion pairs diffusivity.
    Desai D; Wong B; Huang Y; Ye Q; Tang D; Guo H; Huang M; Timmins P
    J Pharm Sci; 2014 Mar; 103(3):920-6. PubMed ID: 24549733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservative Induced Polysorbate 80 Micelle Aggregation.
    Gilbert PH; Zhang Z; Qian KK; Allen DP; Wagner NJ; Liu Y
    J Pharm Sci; 2021 Jun; 110(6):2395-2404. PubMed ID: 33387597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preparation of pellets containing non-ionic surfactants by extrusion/spheronization.
    Podczeck F; Alessi P; Newton JM
    Int J Pharm; 2008 Sep; 361(1-2):33-40. PubMed ID: 18571347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20.
    Webb SD; Cleland JL; Carpenter JF; Randolph TW
    J Pharm Sci; 2002 Feb; 91(2):543-58. PubMed ID: 11835212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of hydrophilic ethoxylates in polysorbate surfactants using diffusion H1 NMR spectroscopy.
    Verbrugghe M; Cocquyt E; Saveyn P; Sabatino P; Sinnaeve D; Martins JC; Van der Meeren P
    J Pharm Biomed Anal; 2010 Feb; 51(3):583-9. PubMed ID: 19846263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.